bell
The current prices are delayed by 15 mins, login to check live prices.
Ajanta Pharma Ltd share price logo

Ajanta Pharma Ltd Share Price

(AJANTPHARM)

₹2875.650.37%

as on 11:19AM, 20 Jan 2025

Overview
News
Financials
Q3 2024 Results
Technicals

Ajanta Pharma Ltd Analyst Rating

based on 10 analysts

BUY

60.00%

Buy

10.00%

Hold

30.00%

Sell

Based on 10 analysts offering long term price targets for Ajanta Pharma Ltd. An average target of ₹3018.5

Source: S&P Global Market Intelligence

Ajanta Pharma Ltd Share analysis

Ajanta Pharma Ltd price forecast by 10 analysts

Upside of5.36%

High

₹3665

Target

₹3018.50

Low

₹1853

Ajanta Pharma Ltd target price ₹3018.5, a slight upside of 5.36% compared to current price of ₹2875.65. According to 10 analysts rating.

Source: S&P Global Market Intelligence

Ajanta Pharma Ltd Performance

  • Day's Low

    Day's High

    ₹2,850.5
    Day's Price Range
    ₹2,888.05
  • 52 Week's Low

    52 Week's High

    ₹1,998.35
    52-Week Price Range
    ₹3,485
1 Month Return-0.05 %
3 Month Return-8.77 %
1 Year Return+ 29.98 %
Previous Close₹2,864.95
Open₹2,877.10
Volume86.75K
Upper Circuit-
Lower Circuit-
Market Cap₹35,786.69Cr

Ajanta Pharma Ltd Key Statistics

P/E Ratio41.17
PEG Ratio2.35
Market Cap₹35,786.69 Cr
P/B Ratio8.28
EPS64.6
Dividend Yield2.29
SectorPharmaceuticals
ROE24.24

Ajanta Pharma Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹35,786.69 Cr51.89%0.51₹816 Cr₹4,208 Cr
BUY₹12,523.02 Cr-3.67%0.52₹602 Cr₹2,851 Cr
BUY₹69,044.08 Cr28.8%0.56₹3,168 Cr₹29,001 Cr
HOLD₹1,00,085.06 Cr54.52%0.64₹3,854 Cr₹19,547 Cr
BUY₹59,350.61 Cr24.18%0.53NANA

About Ajanta Pharma Ltd

Ajanta Pharma is a specialty pharmaceutical company with a wide range of products spanning across 30 countries. It works across therapeutic segments including AntiBiotic AntiMalarial AntiDiabetic Cardiology Gynecology Orthopedics Pediatric Respiratory and General Health products. Founded in 1973, it is headquartered in Mumbai India and has a mission of Serving Global Health Care Needs Worldwide. In their 47 years of operations, they have grown their operations by adding 7 state-of-the-art manufacturing facilities, 2 in India approved by the United States Food and Drug Administration (USFDA). Their Research & Development Centre in Mumbai has a team of over 750 scientists working on innovative products that are supplied to various government bodies in India, the US market and WHO approved programmes in Africa. The company also has 6 subsidiaries and 1 step-down subsidiary worldwide with investments in capex growing from Rs 997 crore to Rs 1225 crore. In addition, the company also has undertaken buybacks of 769230 equity shares in March 2019 and 735000 equity shares in November 2020. 16 new products were launched in FY2022, including 4 1st to market products in the country, 3 new products were launched with 8 ANDAs being filed and receiving 2 final and 1 tentative approval with 20 more pending approval from the USFDA.

Share Price: ₹2875.65 per share as on 20 Jan, 2025 11:19 AM
Market Capitalisation: ₹35,786.69Cr as of today
Revenue: ₹1,186.64Cr as on September 2024 (Q3 24)
Net Profit: ₹216.48Cr as on September 2024 (Q3 24)
Listing date: 29 May, 2000
Chairperson Name: Mannalal B Agrawal
OrganisationAjanta Pharma Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Ajanta Pharma Ltd

  • Brokerage Issues Buy Call for Ajanta Pharma - 08 Jan, 2025

    A brokerage has issued a buy recommendation for Ajanta Pharma Ltd, setting a target price of Rs 3360, indicating a potential upside of 13.30%. A stop loss is advised at Rs 2752.

Insights on Ajanta Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 9.11% to 9.26% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 1.08K Cr → 1.20K Cr (in ₹), with an average increase of 4.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 23.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 22.7%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 66.26% of holdings in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 7.52% to 7.45% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, AJANTPHARM stock has moved down by -4.2%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 14.93% to 14.89% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 245.77 Cr → 216.48 Cr (in ₹), with an average decrease of 11.9% per quarter

Ajanta Pharma Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹1,028.44Cr (-)₹1,105.15Cr (↑7.46%)₹1,054.08Cr (↓4.62%)₹1,144.92Cr (↑8.62%)₹1,186.64Cr (↑3.64%)
Net Income₹195.30Cr (-)₹210.03Cr (↑7.54%)₹202.72Cr (↓3.48%)₹245.77Cr (↑21.24%)₹216.48Cr (↓11.92%)
Net Profit Margin18.99% (-)19.00% (↑0.05%)19.23% (↑1.21%)21.47% (↑11.65%)18.24% (↓15.04%)
Value in ₹ crore
Details2021202220232024
Total Assets₹3,532.06Cr (-)₹3,808.64Cr (↑7.83%)₹4,339.09Cr (↑13.93%)₹4,252.44Cr (↓2.00%)
Total Liabilities₹647.08Cr (-)₹639.46Cr (↓1.18%)₹1,092.64Cr (↑70.87%)₹838.87Cr (↓23.23%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹300.88Cr (-)₹466.99Cr (↑55.21%)₹542.34Cr (↑16.14%)₹736.29Cr (↑35.76%)₹735.35Cr (↓0.13%)

Index Inclusions

BSE Healthcare

₹42,765.84

0.25 (105.58%)

S&P BSE 250 LargeMidCap

₹10,109.84

0.22 (21.76%)

S&P BSE 400 MidSmallCap

₹11,522.02

0.06 (6.64%)

Nifty 500

₹21,769.50

0.41 (89.25%)

Nifty MidSmallcap 400

₹18,995.55

0.09 (16.7%)

NIFTY PHARMA

₹22,127.40

0.3 (65.7%)

BSE Mid-Cap

₹43,726.07

-0.08 (-35.16%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

S&P BSE 150 MidCap

₹15,164.60

0.18 (26.5%)

BSE 500

₹34,223.92

0.41 (140.58%)

Nifty Midcap 150

₹20,205.80

0.05 (9.9%)

Nifty LargeMidcap 250

₹15,206.75

0.17 (26.55%)

Ajanta Pharma Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
66.26%
0.00
Foreign Institutions
9.26%
1.59
Mutual Funds
14.89%
-0.28
Retail Investors
7.45%
-0.87
Others
2.14%
-1.74

Ajanta Pharma Ltd Key Indicators

Details20202021202220232024
Return On Equity %19.1725.2823.7817.4224.24
Details20202021202220232024
Return On Assets %15.3418.5118.7113.5519.19
Details20202021202220232024
Book Value Per Share (₹)197.56229.68253.5268.14282.34
Details20202021202220232024
Earning Per Share (₹)35.5550.1355.3446.5464.6

Ajanta Pharma Ltd Valuation

Ajanta Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (17.12x)

June 6, 2018

Today (41.17x)

January 17, 2025

Industry (54.95x)

January 17, 2025

Highest (50.52x)

September 10, 2024

LowHigh

Ajanta Pharma Ltd Earnings and Dividends

  • Ajanta Pharma Ltd Earnings Results

    Ajanta Pharma Ltd’s net profit jumped 10.84% since last year same period to ₹216.48Cr in the Q2 2024-2025. On a quarterly growth basis, Ajanta Pharma Ltd has generated -11.92% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Ajanta Pharma Ltd Dividends October,2024

    In the quarter ending September 2024, Ajanta Pharma Ltd has declared dividend of ₹28 - translating a dividend yield of 1.88%.

    Read More about Dividends

Ajanta Pharma Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Ajanta Pharma Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Ajanta Pharma Ltd

Ajanta Pharma Ltd share price today stands at ₹2875.65, Open. ₹2877.1 ; Previous Close. ₹2864.95 ; High. ₹2888.05 ; Low. ₹2850.5 ; 52 Week High. ₹3485 ; 52 Week Low: ₹1998.35.

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Ajanta Pharma Ltd shares.

Ajanta Pharma Ltd is listed on NSE

Ajanta Pharma Ltd is listed on BSE

  • Today’s highest price of Ajanta Pharma Ltd is ₹2888.05.
  • Today’s lowest price of Ajanta Pharma Ltd is ₹2850.5.

PE Ratio of Ajanta Pharma Ltd is 41.17

PE ratio = Ajanta Pharma Ltd Market price per share / Ajanta Pharma Ltd Earnings per share

Today’s traded volume of Ajanta Pharma Ltd(AJANTPHARM) is 86.75K.

Today’s market capitalisation of Ajanta Pharma Ltd(AJANTPHARM) is ₹35786.69Cr.

Ajanta Pharma Ltd(AJANTPHARMPrice
52 Week High
₹3485
52 Week Low
₹1998.35

Ajanta Pharma Ltd(AJANTPHARM) share price is ₹2875.65. It is down -17.48% from its 52 Week High price of ₹3485

Ajanta Pharma Ltd(AJANTPHARM) share price is ₹2875.65. It is up 43.90% from its 52 Week Low price of ₹1998.35

Ajanta Pharma Ltd(AJANTPHARMReturns
1 Day Returns
10.7%
1 Month Returns
-0.05%
3 Month Returns
-8.77%
1 Year Returns
29.98%